Venus Remedies (VENUSREM.NS) Earnings Analysis
Venus Remedies (VENUSREM.NS) has no confirmed upcoming earnings date. Trailing P/E 21.58.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does VENUSREM.NS next report earnings?
No confirmed upcoming earnings date is currently scheduled for VENUSREM.NS. This page updates as the calendar is published.
VENUSREM.NS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-30 | 15.06 INR | n/a | n/a | n/a |
| 2025-06-30 | 7.18 INR | n/a | n/a | n/a |
| 2025-05-26 | 15.71 INR | n/a | n/a | n/a |
VENUSREM.NS valuation and analyst view
| Trailing P/E | 21.58 |
|---|---|
| Trailing EPS | 76.912 INR |
| Price / book | 3.34 |
| Dividend yield | 0.00% |
| Market cap | 22.55B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Venus Remedies (VENUSREM.NS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for VENUSREM.NS. This page updates as the calendar is published.
Did VENUSREM.NS beat earnings last quarter?
Consensus estimate data was not available for VENUSREM.NS's 2025-09-30 report.
What is VENUSREM.NS's current P/E ratio and EPS?
VENUSREM.NS trades at a trailing P/E of 21.58 on trailing EPS of 76.91156666167889 INR.
What do analysts rate VENUSREM.NS?
VENUSREM.NS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.